prikaz prve stranice dokumenta Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents
Rad je dostupan svim korisnicima iz sustava znanosti i visokog obrazovanja RH
Stručni rad - Stručni rad
Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents
Pediatric Blood & Cancer, (2021); 29017. https://doi.org/10.1002/pbc.29017
Schneider, Dominik T.; Orbach, Daniel; Ben‐Ami, Tal; Bien, Ewa; Bisogno, Gianni; Brecht, Ines B.; Cecchetto, Giovanni; Ferrari, Andrea; Godzinski, Jan; Janic, Dragana; Lopez Almaraz, Ricardo; Pourtsidis, Apostolos; Roganovic, Jelena; Schultz, Kris Ann P.; Stachowicz‐Stencel, Teresa; Fresneau, Brice Više autora...

Citirajte ovaj rad

Schneider, D. T., Orbach, D., Ben‐Ami, T., Bien, E., Bisogno, G., Brecht, I. B. ... Fresneau, B. (2021). Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents. Pediatric Blood & Cancer. doi: 10.1002/pbc.29017

Schneider, Dominik T., et al. "Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents." Pediatric Blood & Cancer, 2021. https://doi.org/10.1002/pbc.29017

Schneider, Dominik T., Daniel Orbach, Tal Ben‐Ami, Ewa Bien, Gianni Bisogno, Ines B. Brecht, Giovanni Cecchetto, et al. "Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents." Pediatric Blood & Cancer (2021). https://doi.org/10.1002/pbc.29017

Schneider, D. T., et al. (2021) 'Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents', Pediatric Blood & Cancer. doi: 10.1002/pbc.29017

Schneider DT, Orbach D, Ben‐Ami T, Bien E, Bisogno G, Brecht IB, i sur.. Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents. Pediatric Blood & Cancer [Internet]. 24.03.2021. [pristupljeno 24.12.2024.]. doi: 10.1002/pbc.29017

D. T. Schneider, et al., "Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents", Pediatric Blood & Cancer, Ožujak 2021. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:578028. [Citirano: 24.12.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:578028
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Consensus recommendations from the EXPeRT/PARTNER groups for the diagnosis and therapy of sex cord stromal tumors in children and adolescents
AutorDominik T. Schneider
AutorDaniel Orbach
AutorTal Ben‐Ami
AutorEwa Bien
AutorGianni Bisogno
AutorInes B. Brecht
AutorGiovanni Cecchetto
AutorAndrea Ferrari
AutorJan Godzinski
AutorDragana Janic
AutorRicardo Lopez Almaraz
AutorApostolos Pourtsidis
AutorJelena Roganovic
AutorKris Ann P. Schultz
AutorTeresa Stachowicz‐Stencel
AutorBrice Fresneau
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za pedijatriju)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
As part of the European Union-funded project designated Paediatric Rare Tumours Network - European Registry (PARTNER), the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) is continuously developing consensus recommendations in order to harmonize standard care for very rare solid tumors of children and adolescents. This paper presents the internationally recognized recommendations for the diagnosis and treatment of sex cord stromal tumors (SCST). The clinical approach to sex cord stromal tumors of the testis (TSCST) and ovary (OSCST) depends on histological differentiation and tumor stage. Virtually all TSCSTs present as localized nonmetastatic tumors, with excellent prognosis after complete resection. In contrast, the prognosis of OSCSTs may be adversely affected by tumor spillage during surgery or presence of metastases. In these cases, cisplatin-based chemotherapy is recommended. Of note, some SCSTs may develop in the context of tumor predisposition syndromes, for example, DICER-1, so that specific follow-up is indicated. SCSTs should be diagnosed and treated according to standardized recommendations that include reference pathology, genetic testing for tumor predisposition syndromes in selected cases, and stratified adjuvant chemotherapy in patients with unfavorable risk profile. To ensure high quality of diagnosis and therapy, patients should be enrolled into prospective registries.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeStručni rad - Stručni rad
Status objavePrihvaćen za objavljivanje
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaPediatric Blood & Cancer
Brojčani podaci29017
p-ISSN1545-5009
e-ISSN1545-5017
DOIhttps://doi.org/10.1002/pbc.29017
URN:NBNurn:nbn:hr:184:578028
Datum objave publikacije2021-03-24
URL dokumentahttps://onlinelibrary.wiley.com/doi/10.1002/pbc.29017
Vrsta resursaTekst
Prava pristupaOgraničen pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2021-04-14 13:36:13